- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/08 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
Patent holdings for IPC class C07D 243/08
Total number of patents in this class: 309
10-year publication summary
14
|
16
|
22
|
18
|
17
|
9
|
15
|
15
|
8
|
10
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3383 |
9 |
Mimetica Pty Ltd | 8 |
7 |
F. Hoffmann-La Roche AG | 7921 |
6 |
Agios Pharmaceuticals, Inc | 216 |
6 |
Astellas Pharma Inc. | 1092 |
6 |
Merck Sharp & Dohme LLC | 3741 |
6 |
Novartis AG | 10850 |
5 |
Bristol-myers Squibb Company | 4893 |
5 |
Boehringer Ingelheim International GmbH | 4648 |
5 |
Massachusetts Institute of Technology | 10055 |
5 |
AstraZeneca AB | 2908 |
4 |
Amgen Inc. | 4044 |
4 |
Novira Therapeutics, Inc. | 32 |
4 |
Receptos LLC | 63 |
4 |
Nxera Pharma UK Limited | 170 |
4 |
Sandoz AG | 1423 |
3 |
Merck Sharp & Dohme Corp. | 2190 |
3 |
Merck Patent GmbH | 5823 |
3 |
Abbott Laboratories | 2398 |
3 |
President and Fellows of Harvard College | 5976 |
3 |
Other owners | 214 |